[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

France Nutraceuticals Industry Outlook to 2017 - Shift from Curative to Preventive Measures to Impel Growth

March 2014 | 41 pages | ID: FBA20192B5DEN
Ken Research Private Ltd

US$ 800.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The present report on 'France Nutraceuticals Industry Outlook to 2017 - Shift from Curative to Preventive Measures to Impel Growth” gives a comprehensive analysis of the industry past, present and future outlook. It provides a detailed analysis of the industry covering various aspects including market size in terms of revenues and market segmentation on the basis of major types such as dietary supplements and functional food and beverages. Additionally the sub-segments of the industry, ongoing trends and developments, government regulations and impact and highlight major players operating in the industry The future projections are included to provide an insight on the prospects in France nutraceuticals industry.

The economy of France has undergone various changes over the span of last six years (2006-2012), majorly affected by the adverse economic environment prevailing in Europe. The nutraceuticals industry has experienced a slow growth rate over the years, adversely affected by constrained consumer spending. France contributed ~% share of the global nutraceuticals industry revenues in 2012. Amongst the two broad segments, functional food and beverages have led the overall market throughout the period of 2006-2012, with dietary supplements forming a smaller share of ~% in 2012.

The nutraceuticals industry in France has largely benefitted from the government’s de-reimbursement policy in drugs. Additionally, in the recent years, prime health agencies operating in France such as Ameli have been promoting the acceptance of generic drugs across the country. This has instigated a defining change in drug consumption pattern of the population, by encouraging them to be better informed about generics and active ingredients.

In France, an approximate 15% of men and 30% of women take dietary supplements at least three days a week. Amongst the most consumed products are magnesium, vitamins B6 and vitamin C supplements. Pharmacies and chemists have been the most favored channels for the purchase of nutraceuticals in the country. However, in the recent years, these modes of distribution have been facing intense competition from the growing retail distribution. Supermarkets and hypermarkets have emerged as convenient channels for the purchase of fortified food and drinks which ensure a better and wide product visibility.

The outlook for the nutraceuticals industry in France is expected to remain constrained in the near term. The performance of functional food and beverages is anticipated to majorly drive the revenues of France nutraceuticals industry over the span of next three years. Although, a reinstating growth has been witnessed by the dietary supplements segment in recent years, the proceeds of the market will largely be dependent upon the improving economic scenario and increasing role of government regulations on nutraceutical products which are predicted to provide necessary impetus to the much-needed consumer confidence.

KEY TOPICS COVERED IN THE REPORT
  • The market size of the France Nutraceuticals industry, functional food & beverages and dietary supplements markets on the basis of revenues.
  • Market segmentation of the France nutraceuticals industry on the basis of Types of Products
  • Market segmentation of the France dietary supplements industry on the basis of distribution channels
  • Market segmentation of the France dietary supplements industry on the basis of benefits derived
  • Competitive landscape and market shares of the major players in the France Dietary Supplements market.
  • Trends and Developments prevailing in the France Nutraceuticals industry
  • Future outlook and projections of the France Nutraceuticals industry on the basis of revenues.
1. FRANCE NUTRACEUTICALS INDUSTRY INTRODUCTION

1.1. Government Rules and Regulations

2. FRANCE NUTRACEUTICALS INDUSTRY MARKET SIZE BY REVENUES, 2006-2012

3. FRANCE NUTRACEUTICALS MARKET SEGMENTATION BY TYPES OF PRODUCTS, 2006-2012

3.1. France Functional Food and Beverages Market Introduction and Size, 2006-2012
3.2. France Dietary Supplements Market Introduction
  3.2.1. France Dietary Supplements Market Size, 2006-2012
  3.2.2. France Dietary Supplements Market Segmentation
    3.2.2.1. By Distribution Channels, 2009-2012
      3.2.2.1.1. By Sales of Different Product Categories through Pharmacies, 2011-2012
      3.2.2.1.2. By Sales of Different Product Categories through Drugstores, 2011-2012
      3.2.2.1.3. By Supermarkets and Hypermarkets, 2011-2012

4. FRANCE NUTRACEUTICALS INDUSTRY COMPETITIVE LANDSCAPE

5. FRANCE NUTRACEUTICALS INDUSTRY TRENDS AND DEVELOPMENTS

6. FRANCE NUTRACEUTICALS INDUSTRY FUTURE OUTLOOK AND PROJECTIONS, 2013-2017

6.1. Cause and Effect Relationship Analysis of France Nutraceuticals Industry

7. MACROECONOMIC FACTORS AFFECTING FRANCE NUTRACEUTICALS INDUSTRY

7.1. Population Aged 40 and Above in France, 2006-2017
7.2. Public Health Expenditure in France, 2006-2017
7.3. Out-of-Pocket Health Expenditure in France, 2006-2017
7.4. Per Capita Household Disposable Income in France, 2006-2017

8. APPENDIX

8.1. Market Definition
8.2. Abbreviations
8.3. Research Methodology
  Data Collection Methods
  Approach
  Variables (Independent and Dependent)
  Multi Factor Based Sensitivity Model
  Final Conclusion
8.4. Disclaimer

LIST OF FIGURES

Figure 1: Market Structure of France Nutraceuticals Industry
Figure 2: France Nutraceuticals Market Size on the Basis of Revenues in USD Million, 2006-2012
Figure 3: France Nutraceuticals Market Segmentation by Product Form on the Basis of Revenue Contribution in Percentage, 2006-2012
Figure 4: France Functional Food and Beverages Market Size on the Basis of Revenues in USD Million, 2006-2012
Figure 5: France Dietary Supplements Market Size on the Basis of Revenues in USD Million, 2006-2012
Figure 6: France Dietary Supplements Market Segmentation by Distribution on the Basis of Revenue Contribution in Percentage, 2009-2012
Figure 7: France Nutraceuticals Industry Future Projections on the Basis of Revenues in USD Million, 2013-2017
Figure 8: Population Aged 40-and above in France in Million, 2006-2017
Figure 9: Public Health Expenditure in France in USD Million, 2006-2017
Figure 10: Out-of-Pocket Health Expenditure in France in USD Million, 2006-2017
Figure 11: Per Capita Household Disposable Income in France in USD, 2006-2017

LIST OF TABLES

Table 1: France Dietary Supplements Market Segmentation by Distribution on the Basis of Revenue Contribution in USD Million, 2009-2012
Table 2: France Dietary Supplements Market Segmentation by Function on the Basis of Revenue Contribution from Pharmacies in Percentage, 2011-2012
Table 3: France Dietary Supplements Market Segmentation by Function on the Basis of Revenue Contribution from Pharmacies in USD Million, 2011-2012
Table 4: France Dietary Supplements Market Segmentation by Function on the Basis of Revenue Contribution from Drugstores in Percentage, 2011-2012
Table 5: France Dietary Supplements Market Segmentation by Function on the Basis of Revenue Contribution from Supermarkets and Hypermarkets in Percentage, 2011-2012
Table 6: Major Companies Operating in the Nutraceuticals Industry of France
Table 7: Cause and Effect Relationship Analysis between Industry Factors and Expected France Nutraceuticals Industry Prospects
Table 8: Correlation Matrix of France Nutraceuticals Industry
Table 9: Regression Coefficients Output


More Publications